Streetbeat News

Stock Prices

LCII

LCI Industries (NYSE:LCII) reported Q2 2024 adjusted EPS of $2.40, beating the estimate of $2.16. Sales were $1.10 billion, surpassing the $1.05 billion estimate and marking an 8.48% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:03 am

ANIP

ANI Pharmaceuticals has revised its 2024 guidance, forecasting adjusted EPS of $4.38-$4.82, up from prior guidance of $4.26-$4.67 and above the consensus of $4.49. The company also updated its net revenue and EBITDA projections, showing significant growth compared to 2023.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:03 am

YUM

Yum Brands (NYSE:YUM) reported Q2 2024 adjusted earnings per share (EPS) of $1.35, surpassing the analyst consensus estimate of $1.33 by 1.5%.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:02 am

BLDR

Builders FirstSource (NYSE:BLDR) reported Q2 2024 adjusted EPS of $3.50, beating the estimate of $3.02 by 15.89%. However, sales of $4.456 billion missed the $4.483 billion estimate by 0.61%, marking a 1.61% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:02 am

BSY

Bentley Systems (NASDAQ:BSY) reported Q2 2024 adjusted EPS of $0.31, beating the $0.23 estimate. Sales were $330.337M, surpassing the $325.073M estimate and marking an 11.32% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:02 am

GENI

Genius Sports (NYSE: GENI) reported Q2 2024 GAAP EPS of $(0.09), missing the $(0.03) estimate by 200%. However, sales of $95.447M beat the $94.213M estimate by 1.31%. EPS decreased by 80% YoY, while sales increased by 9.90% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:02 am

TGTX

TG Therapeutics (NASDAQ:TGTX) reported Q2 2024 GAAP EPS of $0.04, beating the $(0.05) estimate by 180%. Sales were $73.466M, surpassing the $65.893M estimate by 11.49% and marking a 357.05% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:02 am

BLMN

Bloomin Brands (NASDAQ:BLMN) reported Q2 earnings of $0.51 per share, missing the analyst estimate of $0.58. Sales were $1.12 billion, slightly below the $1.13 billion estimate. Both earnings and sales showed a decline compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:02 am

BITB

ETH

ETHA

ETHE

ETHW

FBTC

GBTC

IBIT

Bitcoin and Ethereum ETFs are showing signs of recovery after Monday's market crash, with several ETFs trading higher in the premarket. This follows a significant drop in these ETFs, reflecting global market downtrends. Bitcoin and Ethereum prices have also rebounded, contributing to the recovery.

Portfolio Pulse from Benzinga Neuro

August 06, 2024 | 11:01 am

RYTM

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported Q2 2024 GAAP EPS of $(0.55), beating the estimate of $(0.71) and showing a significant improvement from $(0.82) last year. Sales were $29.078M, also beating the estimate of $28.789M and showing a 51.28% increase from $19.221M last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:01 am